Summary
Updated Aug 31, 2026
Neilesh Shailesh Ghodadra is Chief Medical Officer, Director of Turn Therapeutics Inc. (TTRX). 1 SEC Form 4 filing on record, dated 8 October 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Neilesh Shailesh Ghodadra has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Neilesh Shailesh Ghodadra files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Arthur F. Golden - $193K of TTRX open-market activity in the last 12 months
- Abraham Chesed - $66K of TTRX open-market activity in the last 12 months
- Zuraiz Chaudhary - $50K of TTRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Neilesh Shailesh Ghodadra?
Neilesh Shailesh Ghodadra is a corporate insider, tracked as Chief Medical Officer, Director of Turn Therapeutics Inc. (TTRX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Neilesh Shailesh Ghodadra last file a Form 4?
The only primary Form 4 on record is dated 8 October 2025.
Where can I see all of Neilesh Shailesh Ghodadra's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Neilesh Shailesh Ghodadra and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
